|
|
|
|
Molecular Pharmacology, Vol 12, 16-31, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics
1 Departments of Medicine and Biochemistry, Duke University Medical Center, Durham, North Carolina 27710
Recently developed techniques for directly studying ligand binding to beta adrenergic
receptors with (-)-[3H]alprenolol have been used to delineate in detail the binding
specificity of the adenylate cyclase-coupled beta adrenergic receptors in a model system,
the frog erythrocyte membrane. The abilities of 60 beta adrenergic agents to compete for
the binding sites and to interact with the adenylate cyclase (as agonists or antagonists)
were quantitated and compared. The specificity of the receptors determined by direct
binding studies or by adenylate cyclase studies was comparable. The KD values of the
agents as determined by inhibition of (-)-[3H]alprenolol binding correlated well (r =
0.95) with their apparent dissociation constants determined by enzyme studies. The
latter were determined as the concentrations of agonists necessary to cause 50% maximal enzyme stimulation, or the concentrations of antagonists necessary to produce a 2-fold rightward shift in the (-)-isoproterenol dose-response curve. Agonists and antagonists appeared to compete for the same set of receptor binding sites. Structure-activity
relationships determined by the direct binding studies were in excellent agreement with
those previously determined in more intact tissue preparations. For agonists the structural features which determined receptor affinity (assessed by direct binding studies)
were distinct from those which determined intrinsic activity (maximum ability to
stimulate adenylate cyclase). The affinity of agonists was increased by increasing the
size of the substituent on the amino nitrogen, by a (-) configuration of the hydroxyl on
the
-carbon, and by the presence of a catechol moiety. Methyl or ethyl substitution on
the
-carbon had only a slight (generally inhibitory) effect on affinity. Intrinsic activity
of agonists was determined primarily by the nature of the substituents on the phenyl
ring. Full intrinsic activity requires the presence of hydroxyl groups on the ring at
positions 3 and 4 as well as the
-carbon hydroxyl in the (-) configuration. Deletion of
the
-carbon hydroxyl, as in compounds such as dopamine, dobutamine, and related
agents, leads to substantial loss of intrinsic activity and affinity even in the presence of
large amino nitrogen substituents. A methanesulfonamide group substituted for the
hydroxyl in position 3 on the ring results in reduced intrinsic activity. Deletion of the
ring hydroxyl at either position 3 or 4 or substitution by chlorine produces competitive
antagonists. Structure-activity relationships of antagonists were similar to those of
agonists, except that the catechol moiety was replaced by a single or double aromatic
ring structure. Separation of this moiety from the ethanolamine side chain by an ether
function significantly increased affinity. When a phenyl group was present, a single
substituent at the para position was associated with reduced affinity.
Note:
ACKNOWLEDGMENT
We gratefully acknowledge the expert assistance
of the analytical chemistry department of New England Nuclear Corporation in developing chromatographic procedures for (-)-alprenolol.
This article has been cited by other articles:
![]() |
P. C. Simons, S. M. Biggs, A. Waller, T. Foutz, D. F. Cimino, Q. Guo, R. R. Neubig, W.-J. Tang, E. R. Prossnitz, and L. A. Sklar Real-time Analysis of Ternary Complex on Particles: DIRECT EVIDENCE FOR PARTIAL AGONISM AT THE AGONIST-RECEPTOR-G PROTEIN COMPLEX ASSEMBLY STEP OF SIGNAL TRANSDUCTION J. Biol. Chem., April 2, 2004; 279(14): 13514 - 13521. [Abstract] [Full Text] [PDF] |
||||